What's the indications of the equine cold laser therapy?
- Pain Relief,Knee Arthritis, Rheumatoid Arthritis Athletics Systemlnjuries Soft Tissue Injuries Sports Injuries & Sprain Wound &
- Ulcer Acupuncture DiminishInflammation Acupuncture
- Rehabilitation Therapy

What's the technical parameter of the equine cold laser therapy?
Technical Specification |
|
Battery capacity |
built-in lithium battery 5600mAh |
Laser wavelength |
808nm±20nm and 650nm±20nm |
Terminal laser output |
3 laser beams with 808nm, 150mw each laser beam, invisible output |
Customized |
can be customized as the LED light therapy or the comb, the different wavelength and power intensity is accepted, if you have the customized requirements, pls contact us directly. |
Case Material |
ABS |
Lens Material |
tempered glass |
Working mode |
Pulse and continuous mode adjusted by self |
Time setting |
15-60 minutes, 10 grades adjustable, each grade increase 5 minutes ( 15mins, 20mins, 25mins, ..., 50mins, 55mins, 60mins ) |
Output power |
170mW, 340mW, 510mW optional |
What is the Functions of the COZING-T03?
① Cozing-T03 can reduce pain and inflammation, reduce swelling, and promote blood flow and circulation. Physical therapy helps the body heal faster.
② Cozing-T03 is good for animal arthritis, animal wound healing, and acute and chronic diseases related to the animal body, legs and head.
③. Cozing-T03 can also help speed up the recovery of animals after surgery.

what is equine cold laser therapy working Principle?
①Low level laser therapy, It is considered to be non-invasive, painless and safe. Low Level Laser Therapy (LLLT) uses laser light energy to stimulate cells to function optimally. ②In the body, light sensitive chromophores and other elements within the cell absorb energy, initiating a series of important photochemical changes such as increased production of ATP. ③The mitochondria and Kreb's Cycle stimulation initiates the production of ATP, providing the cell with the extra energy needed to accelerate the healing process and positively influence pain. ④These activities can occur in all types of cells and includes ligament, nerves,cartilage and muscle.

Product Display:
How to Use? |
|
1st week |
Start with the secondary power on pulse mode |
2nd week |
Adjust to maximum power on pulse mode |
3rd week |
You can start using it on maximum power on constant mode |
Duration: |
Please use 2-3 times a day for about 10-20 minutes. You can set 15x time settings, 15-60 minutes |
Distance from Skin: |
Keep a little distance of 1-2 inches away from the skin |
Clinical Assessment
①Twenty six horses were included in this study with 29 tendon and ligament injuries. The following tendinopathies and desmopathies were diagnosed: SDFT (n = 12; 41%), DDFT (n = 8; 28%; including three horses with injury of the accessory ligament of DDFT) and SL (n = 9; 31%; including three horses with injury of SL body and six horses with injury of SL branches). In nineteen horses (73%) injuries involved front limbs, and in seven horses (27%) injuries were located in the hind limbs. Two of the horses were diagnosed with an injury of SDFT and SL in the same limb, and one horse had an injury of SL in both front limbs. Twenty three tendons and ligaments were randomly assigned to group HILT, and six tendons and ligaments were assigned to group C. For the horse with an injury of SL in both front limbs, the left limb was assigned to group HILT and the right limb was assigned to group C. All the horses completed all treatments and measurements. No statistically significant differences were found between group HILT and group C at day 0 in the clinical assessment and ultrasonographic examinations. No abnormalities in behaviour, general condition or appetite were noticed during and after HILT application.
②Pain There was no statistically significant difference between group HILT and group C during treatment in pain response for tendon and ligament palpation scores (p = 0.100). After treatment, in group C pain scores were significantly higher compared with group HILT (p = 0.023). Furthermore, pain reduction after treatment was statistically significant in group HILT (p = 0.001), while in group C no statistically significant pain reduction was observed (p = 0.895; Figure 1, Table 1).
③Swelling In the control group, the relative swelling systematically decreased, but the differences were not significant (p = 0.667). In group HILT, the relative swelling decreased when comparing the results before and during treatment (6.4 % vs. 4.2%), and this difference was on the border of significance (p = 0.072). At the end of the study, when comparing the results before and after treatment, the difference was significant (6.4% vs. 2.4%; p = 0.001). Additionally, there was a statistically significant difference between group HILT and group C in relative swelling reduction measured during treatment (4.2% vs. 7.8%; p = 0.024) and after treatment (2.4% vs. 6.8%; p = 0.008; Figure 2, Table 2).
FAQ